Archive.fm

ASHPOfficial

Advocating for Impact: 340B under attack

The 340B program is under attack from CMS and drug manufacturers. Tom Kraus and Jillanne Schulte-Wall help you understand recent threats to the program and how ASHP is fighting back. The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Broadcast on:
15 Oct 2020

The 340B program is under attack from CMS and drug manufacturers. Tom Kraus and Jillanne Schulte-Wall help you understand recent threats to the program and how ASHP is fighting back.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.